2022 Remdesivir Market Advance Technology, Business Overview, Forecast 2031Posted by ramacharitbrc on February 11th, 2022 Remdesivir Global Market Report 2022 by The Business Research Company is the most comprehensive report available on the market, being wide-ranging both in terms of chronology and geography. It covers the historic period – 2016-2021, and the forecast period – 2022-2026, with additional forecasts for 2026-2031. The report helps gain a truly global perspective as it covers 60 geographies, focusing on major economies in each region – Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. TBRC’s market report includes a chapter on the COVID-19 impact on the remdesivir industry, which gives valuable insights on supply chain disruptions, logistical challenges, and other economic implications of the virus on the market and how companies can strategize to bounce back from it. With updated market numbers according to the effects of the coronavirus, the report provides the most accurate expected remdesivir market growth numbers from 2022-2031. Request a Sample of the report: The global remdesivir market size is expected to grow from .87 billion in 2021 to .77 billion in 2022 at a compound annual growth rate (CAGR) of 31.2%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The remdesivir market is expected to reach .17 billion in 2026 at a CAGR of 31.2%. View more on the report: https://www.thebusinessresearchcompany.com/report/remdesivir-global-market-report The Remdesivir Global Market Report 2022-31 by The Business Research Company evaluates remdesivir market size, growth rate, drivers, remdesivir industry trends, and major companies. The remdesivir market segments in the report are: 1) By Route of Administration: Oral, Intravenous 2) By Dosage Form: Tablets, Frozen Solution, Lyophilized Solution 3) By Distribution Channel: Hospitals, Clinics, Drug Stores/Pharmacies, Online, Others The table of contents in TBRC’s remdesivir market report includes:
Contact Information: The Business Research Company Asia: +91 88972 63534 Americas: +1 315 623 0293 Like it? Share it!More by this author |